Zusammenfassung
Die Therapie des Mammakarzinoms ist in den letzten Jahren durch 2 Aspekte wesentlich beeinflußt worden.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Early breast cancer trialists’ collaborative group. Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. New Engl J Med 319: 1681–1692, 1988
Henderson I.C.: Adjuvant systemic therapy of early breast cancer and endocrine therapy of metastatic breast cancer. In: Harris J.R., Hellman S., Henderson I.C., Kinne D.W., eds. Breast diseases. Philadelphia: Lippincot J.B., 324–353, 1987
Jonat W., Kaufmann M., Abel U.: Chemo- or Endocrine Adjuvant Therapy Alone or Combined in Postmenopausal Patients (GABG Trial 1). In: Senn HJ., Goldhirsch A., Gelber R.D., Osterwalder B. (eds) Recent Results in Cancer Research: Adjuvant Therapy of Primary Breast Cancer 163–169, 1989
Kaufmann M., Jonat W., Abel U.: Adjuvant Chemo- and Endocrine Therapy Alone or in Combination in Premenopausal Patients (GABG Trial 1). In: Senn H.J., Goldhirsch A., Gelber R.D., Osterwalder B. (eds) Recent Results in Cancer Research: Adjuvant Therapy of Primary Breast Cancer 118–125, 1989
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Jonat, W. (1992). Die Behandlung des Mammakarzinoms Therapiekonzept der neunziger Jahre. In: Ladner, HA., Pfleiderer, A., Profous, C.Z. (eds) Gynäkologische Radiologie. AGO Arbeitsgemeinschaft für Gynäkologische Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-77667-0_18
Download citation
DOI: https://doi.org/10.1007/978-3-642-77667-0_18
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-55726-5
Online ISBN: 978-3-642-77667-0
eBook Packages: Springer Book Archive